Chidamide in Combination With Azacitidine, Liposomal Mitoxantrone, and Prednisone (CAMP Regimen) for the Treatment of Previously Untreated Nodal TFH Cell Lymphoma

NCT05958719 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Peripheral T Cell Lymphoma
Epigenetic Repression

Interventions

DRUG: Chidamide
DRUG: Azacitidine
DRUG: liposomal mitoxantrone
DRUG: prednisone

Sponsor

Institute of Hematology & Blood Diseases Hospital, China